Literature DB >> 7715458

The site-specific recombination system regulating expression of the type 1 fimbrial subunit gene of Escherichia coli is sensitive to changes in DNA supercoiling.

S L Dove1, C J Dorman.   

Abstract

We have studied the effect of altering the in vivo level of DNA supercoiling on the phase-variable expression of the Escherichia coli fimA gene. Transcription from the fimA promoter was unaffected by changes in DNA supercoiling whether caused by the introduction of a topA::Tn10 mutation or by inhibition of DNA gyrase with the antibiotic novobiocin. However, inversion of the fimA promoter fragment was altered in response to perturbation of DNA supercoiling. Specifically, inactivation of topA reduced the rate of promoter fragment inversion in both the ON-to-OFF and the OFF-to-ON directions. This effect correlated with the loss of functional topA and not with the global level of DNA supercoiling. Inhibition of DNA gyrase introduced a bias in favour of the OFF-to-ON inversion; the ON-to-OFF inversion was affected only slightly. Changes in expression of fimB, the gene coding for the recombinase that catalyses fimA promoter fragment inversion in the strains used in this study, did not correlate with effects on fimA phase variation: we found that transcription of fimB was inhibited by loss of functional topA and was enhanced by inhibition of DNA gyrase in a manner that correlated well with the global level of in vivo DNA supercoiling. A model is presented to account for the effects of lost topoisomerase function on fimA gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7715458     DOI: 10.1111/j.1365-2958.1994.tb01332.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  15 in total

1.  Interaction of the FimB integrase with the fimS invertible DNA element in Escherichia coli in vivo and in vitro.

Authors:  L S Burns; S G Smith; C J Dorman
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Osmolarity and pH growth conditions regulate fim gene transcription and type 1 pilus expression in uropathogenic Escherichia coli.

Authors:  William R Schwan; Jeffrey L Lee; Farrah A Lenard; Brian T Matthews; Michael T Beck
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.

Authors:  S Bagel; V Hüllen; B Wiedemann; P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 4.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  DNA supercoiling and the Lrp protein determine the directionality of fim switch DNA inversion in Escherichia coli K-12.

Authors:  Arlene Kelly; Colin Conway; Tadhg O Cróinín; Stephen G J Smith; Charles J Dorman
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  Direct observation of type 1 fimbrial switching.

Authors:  Aileen M Adiciptaningrum; Ian C Blomfield; Sander J Tans
Journal:  EMBO Rep       Date:  2009-03-27       Impact factor: 8.807

Review 7.  The regulatory role of DNA supercoiling in nucleoprotein complex assembly and genetic activity.

Authors:  Georgi Muskhelishvili; Andrew Travers
Journal:  Biophys Rev       Date:  2016-11-19

8.  Differential control of transcription-induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro.

Authors:  Z Wang; P Dröge
Journal:  EMBO J       Date:  1996-02-01       Impact factor: 11.598

9.  Effects of a Mutation in the gyrA Gene on the Virulence of Uropathogenic Escherichia coli.

Authors:  Javier Sánchez-Céspedes; Emma Sáez-López; N Frimodt-Møller; Jordi Vila; Sara M Soto
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

10.  Type 1 fimbriae, a colonization factor of uropathogenic Escherichia coli, are controlled by the metabolic sensor CRP-cAMP.

Authors:  Claudia M Müller; Anna Aberg; Jurate Straseviçiene; Levente Emody; Bernt Eric Uhlin; Carlos Balsalobre
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.